Kinase mutations in human disease: interpreting genotype–phenotype relationships

Lahiry, Piya, Torkamani, Ali, Schork, Nicholas J., Hegele, Robert A.·2010·Nature Reviews Genetics

DOI 10.1038/nrg2707

Cited by (429)

Items 101–200 of 429

Crystal structures of S6K1 provide insights into the regulation mechanism of S6K1 by the hydrophobic motif
Jianchuan Wang, Chen Zhong, Fang Wang, Fangfang Qu, Jianping Ding · 2013 · Biochemical Journal
Combating mutations in genetic disease and drug resistance: understanding molecular mechanisms to guide drug design
Amanda T. S. Albanaz, Carlos H. M. Rodrigues, Douglas E. V. Pires, David Benjamin Ascher · 2017 · Expert Opinion on Drug Discovery
Gene susceptibility to oxidative damage: From single nucleotide polymorphisms to function
Valeria Simonelli, Filomena Mazzei, Mariarosaria D’Errico, Eugenia Dogliotti Y · 2011 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase Inhibitors
Federica Fabro, Martine L.M. Lamfers, Sieger Leenstra · 2022 · Cancers
Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis
So Masaki, Isao Kii, Yuto Sumida, Tomoe Kato‐Sumida, Yasushi Ogawa, Nobutoshi Ito, Mitsuhiro Nakamura, Rie Sonamoto, Naoyuki Kataoka, Takamitsu Hosoya et al. · 2015 · Bioorganic & Medicinal Chemistry
A comprehensive genomic meta-analysis identifies confirmatory role of OBSCN gene in breast tumorigenesis
Rajendran, Barani Kumar, Deng, Chu-Xia · 2017 · Oncotarget
Characterization of covalent binding of tyrosine kinase inhibitors to plasma proteins
Liu, Xiaoyun, Feng, Dan, Zheng, Mingyue, Cui, Yongmei, Zhong, Dafang · 2020 · Drug Metabolism and Pharmacokinetics
Kinact: a computational approach for predicting activating missense mutations in protein kinases
Rodrigues, Carlos HM, Ascher, David B, Pires, Douglas EV · 2018 · Nucleic Acids Research
Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells
Elena V. Tibaldi, Mario Angelo Pagano, Federica Frezzato, Valentina Trimarco, Monica Facco, Giuseppe Zagotto, Giovanni Ribaudo, Valeria Pavan, Luciana Bordin, Andrea Visentin et al. · 2017 · Haematologica
Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: A cross-sectional study
Anna Zampetti, Gabriella Silvestri, Simona Manco, Katy Khamis, Marcella Masciullo, Maria Laura Ester Bianchi, Antonello Damiani, Massimo Santoro, Dennis Linder, Anthony Bewley et al. · 2014 · Journal of the American Academy of Dermatology
Sequence and Structure-Based Analysis of Specificity Determinants in Eukaryotic Protein Kinases
David T. Carreon Bradley, Cristina Viéitez, Vinothini Rajeeve, Joel Selkrig, Pedro R. Cutillas, Pedro Beltrão · 2021 · Cell Reports
Identification of two poorly prognosed ovarian carcinoma subtypes associated withCHEK2germ-line mutation and non-CHEK2somatic mutation gene signatures
Ghim Siong Ow, Anna V. Ivshina, Gloria Fuentes, Vladimir A. Kuznetsov · 2014 · Cell Cycle
Augmentation du risque de tumeurs dans la dystrophie myotonique de type 1
S. Mohamed, Lelia Pruna, P. Kaminsky · 2013 · La Presse Médicale
Integrative annotation and knowledge discovery of kinase post-translational modifications and cancer-associated mutations through federated protein ontologies and resources
Liang‐Chin Huang, Karen E. ROSS, Timothy R. Baffi, Harold Drabkin, Krzysztof Kochut, Zheng Ruan, Peter D’Eustachio, Daniel Ian McSkimming, Cecilia N. Arighi, Chuming Chen et al. · 2018 · Scientific Reports
Predictive Models for Fast and Effective Profiling of Kinase Inhibitors
Alina Bora, Sorin I. Avram, Ionel Ciucanu, Marius Raica, Ștefana Avram · 2016 · Journal of Chemical Information and Modeling
Coevolutionary Landscape of Kinase Family Proteins: Sequence Probabilities and Functional Motifs
Allan Haldane, William F. Flynn, Peng He, Ronald M. Levy · 2018 · Biophysical Journal
Overview of Current Type I/II Kinase Inhibitors
Zheng Zhao, Philip E. Bourne · 2020 · Springer eBooks
Chemical probes targeting the kinase CK2: a journey outside the catalytic box
Jessica Iegre, Eleanor L. Atkinson, Paul D. Brear, Bethany M. Cooper, Marko Hyvönen, David R. Spring · 2021 · Organic & Biomolecular Chemistry
Human SBK1 is dysregulated in multiple cancers and promotes survival of ovary cancer SK-OV-3 cells
Pingzhang Wang, Jinhai Guo, Feng Wang, Taiping Shi, Dalong Ma · 2010 · Molecular Biology Reports
Cushing's syndrome mutant PKA L 205R exhibits altered substrate specificity
Joshua M. Lubner, Kimberly L. Dodge‐Kafka, Cathrine Rein Carlson, George McDonald Church, Michael F. Chou, Daniel Schwartz · 2017 · FEBS Letters
Ancestral reconstruction reveals mechanisms of ERK regulatory evolution
Dajun Sang, Sudarshan Pinglay, Rafal Wiewiora, Myvizhi Esai Selvan, Hua Jane Lou, John D. Chodera, Benjamin E. Turk, Zeynep Hulya Gumus, Liam J. Holt · 2019 · eLife
Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases
Rima Hajjo, Dima A. Sabbah, Osama H. Abusara, Reham Kharmah, Sanaa K. Bardaweel · 2023 · Viruses
Positional distribution and conservation of major phosphorylated sites in the human kinome
Athira Perunelly Gopalakrishnan, Prathik Basthikoppa Shivamurthy, Mukhtar Ahmed, Samseera Ummar, Poornima Ramesh, Sonet Daniel Thomas, Althaf Mahin, Mahammad Nisar, Sowmya Soman, Yashwanth Subbannayya et al. · 2025 · Frontiers in Molecular Biosciences
Interplay between receptor tyrosine kinases and hypoxia signaling in cancer
Astrid A. Glück, Daniel M. Aebersold, Yitzhak Zimmer, Michaela Medová · 2015 · The International Journal of Biochemistry & Cell Biology
Targeted mass spectrometry: An emerging powerful approach to unblock the bottleneck in phosphoproteomics
Nerea Osinalde, Kerman Aloria, Miren Josu Omaetxebarria Ibarra, Irina Kratchmarova · 2017 · Journal of Chromatography B
SLC6A1 variant pathogenicity, molecular function and phenotype: a genetic and clinical analysis
Arthur Stefanski, Eduardo Pérez‐Palma, Tobias Brünger, Ludovica Montanucci, Cornelius Gati, Chiara Klöckner, Katrine M. Johannesen, Kimberly Goodspeed, Marie Macnee, Alexander T. Deng et al. · 2023 · Brain
Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer
Sara K. Jaradat, Nehad M. Ayoub, Ahmed Hesham Al Sharie, Julia M. Aldaod · 2024 · Technology in Cancer Research & Treatment
RNA interference-mediated URG4 gene silencing diminishes cyclin D1 mRNA expression in HepG2 cells
N. Lale Şatıroğlu-Tufan, Yavuz Dodurga, Duygu Gök, Ayşe Çetinkaya, Mark A. Feitelson · 2010 · Genetics and Molecular Research
Kinase Inhibitor Scaffold Hopping with Deep Learning Approaches
Lizhao Hu, Yuyao Yang, Shuangjia Zheng, Jun Xu, Ting Ran, Hongming Chen · 2021 · Journal of Chemical Information and Modeling
Targeting Dynamic ATP-Binding Site Features Allows Discrimination between Highly Homologous Protein Kinases
Sujata Chakraborty, Takayuki Inukai, Linglan Fang, Martin G. Golkowski, Dustin J. Maly · 2019 · ACS Chemical Biology
Identifying Kinase Substrates via a Heavy ATP Kinase Assay and Quantitative Mass Spectrometry
André C. Müller, Roberto Giambruno, Juliane Weißer, Peter Májek, Alexandre Hofer, Johannes W. Bigenzahn, Giulio Superti‐Furga, Henning Jacob Jessen, Keiryn L. Bennett · 2016 · Scientific Reports
Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets
Shirin Elizabeth Khorsandi, Arran David Dokal, Vinothini Rajeeve, David James Britton, Megan S. Illingworth, Nigel David Heaton, Pedro R. Cutillas · 2021 · Cancer Research
Multi-omics analysis identifies drivers of protein phosphorylation
Tian Zhang, Gregory R. Keele, Isabela Gerdes Gyuricza, Matthew J. Vincent, Catherine Brunton, Timothy A. Bell, Pablo Hock, Ginger D. Shaw, Steven C. Munger, Fernando Pardo‐Manuel de Villena et al. · 2023 · Genome biology
Multiple Functional Effects of RET Kinase Domain Sequence Variants in Hirschsprung Disease
Brandy D. Hyndman, Taranjit S. Gujral, Jonathan R. Krieger, Jessica Cockburn, Lois M. Mulligan · 2012 · Human Mutation
An alternatively spliced, non-signaling insulin receptor modulates insulin sensitivity via insulin peptide sequestration in C. elegans
Bryan Martinez, Pedro Reis Rodrigues, Ricardo M Nuñez Medina, Prosenjit Mondal, Neale J Harrison, Museer A. Lone, Amanda Webster, Aditi U. Gurkar, Brock J. Grill, Matthew S Gill · 2020 · eLife
Prioritization of pathogenic mutations in the protein kinase superfamily
José M. G. Izarzugaza, Ángela del Pozo, Miguél Vázquez, Alfonso Valencia · 2012 · BMC Genomics
Advances in reversible covalent kinase inhibitors
Zheng Zhao, Philip E. Bourne · 2024 · Medicinal Research Reviews
Novel Library of Selenocompounds as Kinase Modulators
Daniel Plano, Elena Ibáñez, Alfonso Calvo, Juan Antonio Palop, Carmen Sanmartín · 2011 · Molecules
The Kinome of Pacific Oyster Crassostrea gigas, Its Expression during Development and in Response to Environmental Factors
Yanouk Epelboin, Laure Quintric, Éric Guévélou, Pierre Boudry, Vianney Pichereau, Charlotte Corporeau · 2016 · PLoS ONE
Using molecular simulation to explore the nanoscale dynamics of the plant kinome
Alexander S. Moffett, Diwakar Shukla · 2018 · Biochemical Journal
The prospect of substrate-based kinase inhibitors to improve target selectivity and overcome drug resistance
Biswajit Biswas, Yen‐Hua Huang, David J. Craik, Conan K. L. Wang · 2024 · Chemical Science
Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics
David B. Neale, Jonathan C. Morris, Nicole M. Verrills, Alaina Jean Ammit · 2025 · Pharmacology & Therapeutics
RNA editing restricts hyperactive ciliary kinases
Dongdong Li, Yufan Liu, Peishan Yi, Zhiwen Zhu, Wei Li, Qiangfeng Cliff Zhang, Jin Billy Li, Guangshuo Ou · 2021 · Science
Distinct Involvement of the Gab1 and Grb2 Adaptor Proteins in Signal Transduction by the Related Receptor Tyrosine Kinases RON and MET
Amitabha Chaudhuri, Ming-Hong Xie, Becky Yang, Kaushiki Mahapatra, Jinfeng Liu, Scot A. Marsters, Sweta Bodepudi, Avi Ashkenazi · 2011 · Journal of Biological Chemistry
CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2
Paula Aranaz, C. Hurtado, Ignacio Erquiaga, Itziar Miguéliz, Cristina Ormazabal, Ion Cristóbal, Marina García‐Delgado, Francisco Javier Novo, J.L. Vizmanos · 2012 · Haematologica
Gene of the month: BRAF
Dhirendra Govender, Runjan Chetty · 2012 · Journal of Clinical Pathology
The generality of kinase-catalyzed biotinylation
Chamara Senevirathne, D. Maheeka Embogama, Thilani A. Anthony, Ahmed E. Fouda, Mary Kay H. Pflum · 2015 · Bioorganic & Medicinal Chemistry
Therapeutic Innovations: Tyrosine Kinase Inhibitors in Cancer
Nikolaos G. Dervisis, Shawna L. Klahn · 2016 · Veterinary Sciences
Targeting the DFG-In Kinase Conformation: A New Trend Emerging from a Patent Analysis
Mauro Angiolini · 2011 · Future Medicinal Chemistry
Interrogating Kinase–Substrate Relationships with Proximity Labeling and Phosphorylation Enrichment
Tian Zhang, Anne Fassl, Laura Pontano Vaites, Sipei Fu, Piotr Siciński, João A. Paulo, Steven P. Gygi · 2022 · Journal of Proteome Research
Germline Fitness-Based Scoring of Cancer Mutations
Andrej Fischer, Chris Greenman, Ville Mustonen · 2011 · Genetics
Binding of the anticancer drug BI-2536 to human serum albumin. A spectroscopic and theoretical study
Jesús Fernández-Sainz, Pedro J. Pacheco-Liñán, José M. Granadino‐Roldán, Iván Bravo, Andrés Garzón‐Ruiz, J. Rubio, José Albaladejo · 2017 · Journal of Photochemistry and Photobiology B Biology
KRSA: An R package and R Shiny web application for an end-to-end upstream kinase analysis of kinome array data
Erica A. K. DePasquale, Khaled Alganem, Eduard Bentea, Nawshaba Nawreen, Jennifer L. McGuire, Tushar Tomar, Faris Naji, Riet Hilhorst, Jarek Meller, Robert Erne McCullumsmith · 2021 · PLoS ONE
Systematic Exploration of Privileged Warheads for Covalent Kinase Drug Discovery
Zheng Zhao, Philip E. Bourne · 2022 · Pharmaceuticals
Identification of Small Molecule Inhibitors of PTPσ through an Integrative Virtual and Biochemical Approach
Katie R. Martin, Pooja Narang, Yong Xu, Audra L. Kauffman, Joachim L. Petit, H. Eric Xu, Nathalie Meurice, Jeffrey P. MacKeigan · 2012 · PLoS ONE
The Role of Regulatory Domains in Maintaining Autoinhibition in the Multidomain Kinase PKCα
Ruth F. Sommese, Michael Ritt, Carter J. Swanson, Sivaraj Sivaramakrishnan · 2017 · Journal of Biological Chemistry
Differential regulation of PKD isoforms in oxidative stress conditions through phosphorylation of a conserved Tyr in the P+1 loop
Mathias Cobbaut, Rita Derua, Heike R. Döppler, Hua Jane Lou, Sandy Vandoninck, Peter Störz, Benjamin E. Turk, Thomas Theodor Werner Seufferlein, Etienne Waelkens, Veerle Janssens et al. · 2017 · Scientific Reports
Exploring the conformational landscape of protein kinases
Nancy R. Gough, Charalampos G. Kalodimos · 2024 · Current Opinion in Structural Biology
A comprehensive exploration of the druggable conformational space of protein kinases using AI-predicted structures
Noah B. Herrington, Yan Chak Li, Yan Chak Li, Gaurav Shankar Pandey, Avner Schlessinger · 2024 · PLoS Computational Biology
Chemical biology toolkit for exploring protein kinase catalyzed phosphorylation reactions
Sanela Martić, Heinz‐Bernhard Kraatz · 2012 · Chemical Science
Selective Mitogen Activated Protein Kinase Activity Sensors through the Application of Directionally Programmable D Domain Motifs
Laura B. Peterson, Michael B. Yaffe, Barbara Imperiali · 2014 · Biochemistry
Identification of a Novel Inhibitory Allosteric Site in p38α
Patricia Gómez‐Gutierrez, Pedro M. Campos, Miguel Vega, Juan Jesús Pérez · 2016 · PLoS ONE
Convex hull principle for classification and phylogeny of eukaryotic proteins
Xin Tong Zhao, Kun Tian, Rong Lucy He, Stephen S.‐T. Yau · 2018 · Genomics
mi R ‐214 and hypoxia down‐regulate N ecl‐2/ CADM 1 and enhance E rb B 2/ E rb B 3 signaling
Kenji Momose, Akihiro Minami, Yohei Shimono, Kiyohito Mizutani, Kentaro Nobutani, Takeshi Azuma, Yoshimi Takai · 2013 · Genes to Cells
Conservative treatment of Morton's neuroma.
Graeme Strong, Padmini Thomas · 1987 · PubMed
Gene family information facilitates variant interpretation and identification of disease-associated genes
Dennis Lal, Patrick May, Kaitlin E. Samocha, Jack A. Kosmicki, Elise Robinson, Rikke Steensbjerre Møller, Roland Krause, Peter Nüernberg, Sarah Weckhuysen, Peter De Jonghe et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
Elucidating Common Structural Features of Human Pathogenic Variations Using Large-Scale Atomic-Resolution Protein Networks
Jishnu Das, Hao Ran Lee, Adithya Sagar, Robert Fragoza, Jin Hua Liang, Xiaomu Wei, Xiujuan Wang, Matthew E. Mort, Peter D. Stenson, D.N. Cooper et al. · 2014 · Human Mutation
PhosD: inferring kinase–substrate interactions based on protein domains
Guimin Qin, Ruiyi Li, Xing‐Ming Zhao · 2016 · Bioinformatics
Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death
So Jung Park, Doo Sin Jo, Se‐Young Jo, Dong Woon Shin, Sangmi Shim, Yoon Kyung Jo, Ji Hyun Shin, Ye Jin Ha, Seong‐Yun Jeong, Jung Jin Hwang et al. · 2016 · Oncotarget
KinCon: Cell‐based recording of full‐length kinase conformations
Florian Enzler, Philipp Tschaikner, Rainer Schneider, Eduard Stefan · 2020 · IUBMB Life
Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery
Katie R. Martin, Pooja Narang, José L. Medina‐Franco, Nathalie Meurice, Jeffrey P. MacKeigan · 2013 · Methods
Building and exploring an integrated human kinase network: Global organization and medical entry points
Jacques Colinge, Adrián César‐Razquin, K. Huber, Florian P. Breitwieser, Peter Májek, Giulio Superti‐Furga · 2014 · Journal of Proteomics
Computational Prediction of Post-Translational Modification Sites in Proteins
Yu Xue, Zexian Liu, Jun Cao, Jian Re · 2011 · InTech eBooks
The Role of Protein Structural Analysis in the Next Generation Sequencing Era
Wyatt W. Yue, D. Sean Froese, Paul E. Brennan · 2012 · Topics in current chemistry
Advancing cancer drug development with mechanistic mathematical modeling: bridging the gap between theory and practice
Alexander Jan Kulesza, Claire Couty, Paul Lemarre, Craig J. Thalhauser, Yanguang Cao · 2024 · Journal of Pharmacokinetics and Pharmacodynamics
Methods for investigation of targeted kinase inhibitor therapy using chemical proteomics and phosphorylation profiling
Bin Fang, Eric B. Haura, Keiran S.M. Smalley, Steven A. Eschrich, John M. Koomen · 2010 · Biochemical Pharmacology
Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: Applications to protein kinase CK2
Laszlo Gyenis, Jacob P. Turowec, Maria Bretner, David W. Litchfield · 2013 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Rs1799817 in INSR associates with susceptibility to polycystic ovary syndrome
Maha Hasan Daghestani · 2019 · Journal of Medical Biochemistry
Revealing the Unbinding Kinetics and Mechanism of Type I and Type II Protein Kinase Inhibitors by Local-Scaled Molecular Dynamics Simulations
Yu Du, Renxiao Wang · 2020 · Journal of Chemical Theory and Computation
Validation of an Allosteric Binding Site of Src Kinase Identified by Unbiased Ligand Binding Simulations
Mingione, Victoria R., Foda, Zachariah H., Paung, YiTing, Philipose, Hannah, Rangwala, Aziz M., Shan, Yibing, Seeliger, Markus A. · 2022 · Journal of Molecular Biology
Naphthoquinone as a New Chemical Scaffold for Leishmanicidal Inhibitors of Leishmania GSK-3
Víctor Sebastián-Pérez, Paula Martínez de Iturrate, Montserrat Nachér-Vázquez, Luis Nóvoa, Concepción Pérez, Nuria Eugenia Campillo, Carmen Gil, Luís Rivas · 2022 · Biomedicines
Pathogenic mutation hotspots in protein kinase domain structure
Kirill E. Medvedev, Richard Dustin Schaeffer, Jimin Pei, Nick V. Grishin · 2023 · Protein Science
Genomic pathobiology of gastric carcinoma
H. Katoh, S. Ishikawa · 2017 · Pathology international (Print)
Identification of Potential Small Molecule Binding Pockets in p38α MAP Kinase
Patricia Gómez‐Gutierrez, J. Rubio, Juan Jesús Pérez · 2017 · Journal of Chemical Information and Modeling
Toward a mechanistic explanation of phenotypic evolution: The need for a theory of theory integration
Manfred D. Laubichler, Sonja J. Prohaska, Peter Florian Stadler · 2018 · Journal of Experimental Zoology Part B Molecular and Developmental Evolution
A Gain-of-Function Mutation on BCKDK Gene and Its Possible Pathogenic Role in Branched-Chain Amino Acid Metabolism
Alice Maguolo, Giulia Rodella, Alejandro Giorgetti, Marion Nicolodi, Rui Pedro Ribeiro, Alice Dianin, Gaetano Cantalupo, Irene Monge, Sarah Carcereri, Margherita Lucia De Bernardi et al. · 2022 · Genes
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
Sudarshan R. Iyer, Kevin D. Nusser, Kristen L. Jones, Pushkar Shinde, Catherine Z. Beach, Clare Keddy, Erin Aguero, Jeremy Meyer Force, Ujwal P. Shinde, Monika Ashok Davare · 2023 · EMBO Molecular Medicine
Computational Analysis of Phosphoproteomics: Progresses and Perspectives
Jian Min Ren, Xinjiao Gao, Zexian Liu, Jun Cao, Qian Ma, Yu Xue · 2011 · Current Protein and Peptide Science
Systematic response of staurosporine scaffold‐based inhibitors to drug‐resistant cancer kinase mutations
Yongkang He · 2020 · Archiv der Pharmazie
Active-site cysteine 215 sulfonation targets protein tyrosine phosphatase PTP1B for Cullin1 E3 ligase-mediated degradation
Chunyi Yang, Chiu-Fen Yang, Xiaofang Tang, Luciana E. S. F. Machado, Jai Prakash Singh, Wolfgang Peti, Chien‐Sheng Chen, Tzu‐Ching Meng · 2022 · Free Radical Biology and Medicine
Kinase inhibitors: An overview
Sabeeha Ali, Manzar Alam, Md. Imtaiyaz Hassan · 2022 · Elsevier eBooks
Frequency and type of cancers in myotonic dystrophy: A retrospective cross‐sectional study
Eleonora Silvana D'Ambrosio, Kathy Chuang, William S. David, Anthony A. Amato, Paloma González-Pérez · 2023 · Muscle & Nerve
Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types
Runjun D. Kumar, Ron Bose · 2017 · Scientific Reports
Lowering Sample Requirements to Study Tyrosine Kinase Signaling Using Phosphoproteomics with the TMT Calibrator Approach
Bin Fang, Victoria Izumi, Lily L. Remsing Rix, Eric A. Welsh, Ian Pike, Gary W. Reuther, Eric B. Haura, Uwe Rix, John M. Koomen · 2020 · PROTEOMICS
The first eukaryotic kinome tree illuminates the dynamic history of present-day kinases
Leny M. van Wijk, ‎Berend Snel · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Dissecting the multifaceted roles of autophagy in cancer initiation, growth, and metastasis: from molecular mechanisms to therapeutic applications
Afia Ayub, Md. Kamrul Hasan, Zimam Mahmud, Md. Sabbir Hossain, Yearul Kabir · 2024 · Medical Oncology
A chemoproteomic method for identifying cellular targets of covalent kinase inhibitors
Ying-Chu Chen, Chao Zhang · 2016 · Genes & Cancer
Advances in mass spectrometry based strategies to study receptor tyrosine kinases
Simon Vyse, H. Desmond, Paul H. Huang · 2017 · IUCrJ
Beyond history and “on a roll”: The list of the most well‐studied human protein structures and overall trends in the protein data bank
Zhenlu Li, Matthias Buck · 2021 · Protein Science
Prediction of kinase–substrate relations based on heterogeneous networks
Haichun Li, Minghui Wang, Xiaoyi Xu · 2015 · Journal of Bioinformatics and Computational Biology